Author

Guido Cavaletti

universit

Biography

Myself Guido Cavaletti. I am from Italy, I am from Experimental Neurology Unit, Department of Surgery and Translational Medicine, University of Milano-Bicocca, Monza, Monash, Australia. My area of interests are Relapsing-Remitting EAE; MSC; Clinical score; Demyelination; Active microglia; Recovery
Title
Cited by
Year
Exercise and neuropathy: Systematic review with meta-analysis
F Streckmann, M Balke, G Cavaletti, A Toscanelli, W Bloch, BF Décard, ...Sports Medicine 52 (5), 1043-1065, 202
22
2022
ESMO Expert Consensus Statements on Cancer Survivorship: Promoting high-quality survivorship care and research in Europe
I Vaz-Luis, M Masiero, G Cavaletti, A Cervantes, RT Chlebowski, ...Annals of Oncology 33 (11), 1119-1133, 202
22
2022
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients
S Karteri, J Bruna, AA Argyriou, S Mariotto, R Velasco, M Alemany, ...Journal of the Peripheral Nervous System 27 (2), 166-174, 2022202
13
2022
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database
G Liberatore, A De Lorenzo, C Giannotta, F Manganelli, M Filosto, ...Neurological Sciences 43 (6), 3939-3947, 2022202
8
2022
Neurons: the interplay between cytoskeleton, ion channels/transporters and mitochondria
P Alberti, S Semperboni, G Cavaletti, A ScuteriCells 11 (16), 2499, 2022202
7
2022
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values
S Arends, J Drenthen, P van den Bergh, H Franssen, RDM Hadden, ...Clinical Neurophysiology 138, 231-20, 2022202
4
2022
Calmangafodipir for prevention of oxaliplatin-induced peripheral neuropathy: two placebo-controlled, randomized phase 3 studies (POLAR-A/POLAR-M)
P Pfeiffer, M Lustberg, J Näsström, S Carlsson, A Persson, F Nagahama, ...JNCI Cancer Spectrum 6 (6), pkac075, 2022202
4
2022
Disease-modifying treatments and time to loss of ambulatory function in patients with primary progressive multiple sclerosis
E Portaccio, M Fonderico, P Iaffaldano, L Pastò, L Razzolini, A Bellinvia, ...JAMA neurology 79 (9), 869-878, 2022202
4
2022
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons
O Tarasiuk, E Ballarini, E Donzelli, V Rodriguez-Menendez, M Bossi, ...International Journal of Molecular Sciences 2 (10), 5791, 2022202
3
2022
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration
M De Santo, A Giovinazzo, M Fava, E Mazzotta, IE De Napoli, M Greco, ...Materials Chemistry Frontiers 7 (2), 216-229, 20220
3
2023
Neurological complications of conventional and novel anticancer treatments
P Alberti, A Salvalaggio, AA Argyriou, J Bruna, A Visentin, G Cavaletti, ...Cancers 14 (24), 6088, 2022202
3
2022
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
E Ballarini, A Malacrida, V Rodriguez-Menendez, E Pozzi, A Canta, ...International Journal of Molecular Sciences 2 (17), 1006, 2022202
3
2022
From Nature to Synthetic Compounds: novel 1 (N), 2, 3 Trisubstituted-5-oxopyrrolidines targeting multiple myeloma cells
From Nature to Synthetic Compounds: novel 1 (N), , 3 Trisubstituted-5-oxopyrrolidines targeting multiple myeloma cellsR Listro, A Malacrida, FA Ambrosio, G Rossino, M Di Giacomo, ...International Journal of Molecular Sciences 3 (1), 13061, 0
2
2022
Ubiquitin proteasome system and microtubules are master regulators of central and peripheral nervous system axon degeneration
D Cartelli, G Cavaletti, G Lauria, C MeregalliCells 11 (8), 1358, 0
2
2022
Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register
R Bergamaschi, E Beghi, C Bosetti, M Ponzio, C Santucci, V Lepore, ...Neurological Sciences 43 (9), 5459-5469, 0
2
2022
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity
E Pozzi, E Ballarini, V Rodriguez-Menendez, A Canta, A Chiorazzi, ...Toxics 11 (), 93, 030
2
2023
CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barré syndrome
H Al-Hakem, AY Doets, AM Stino, SA Zivkovic, H Andersen, HJ Willison, ...Neurology 00 (23), e2386-e2397, 2023202
1
2023
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells
A Malacrida, J Erriquez, M Hashemi, V Rodriguez-Menendez, A Cassetti, ...Biochemistry and Biophysics Reports 32, 0353, 2022202
1
2022
K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected Multiple Sclerosis
C Cutellè, C Balducci, D Cereda, ML Fusco, D Iacobucci, J Perugini, ...Journal of Neuroimmunology 373, 577992, 2022202
1
2022
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
A Canta, VA Carozzi, A Chiorazzi, C Meregalli, N Oggioni, ...Biomedicines (), 20, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=ZBKrb4wAAAAJ&hl=it

Cited by
Citations 24425
h-index 81
i10-index 298
Recommended Journals
Open Access Journals